Analytical and pharmacokinetic studies on butyrophenones.
D000273:Adipose Tissue / Q000378:metabolism; D000284:Administration, Oral; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002090:Butyrophenones / Q000032:analysis* / Q000378:metabolism; D002849:Chromatography, Gas; D003640:Dealkylation; D003864:Depression, Chemical; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors; D005215:Fasting; D006220:Haloperidol / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D013058:Mass Spectrometry; D001523:Mental Disorders / Q000188:drug therapy; D008722:Methods; D008862:Microsomes, Liver / Q000378:metabolism; D010084:Oxidation-Reduction; D051381:Rats; D013997:Time Factors; D014272:Trifluperidol / Q000032:analysis / Q000097:blood / Q000378:metabolism*
D002090:Butyrophenones; D006220:Haloperidol; D014272:Trifluperidol; D003913:Dextroamphetamine